Comparison between CSB Bank IPO and Rossari Biotech IPO.
CSB Bank IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Rossari Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of CSB Bank IPO is up to ₹409.68 Cr whereas the issue size of the Rossari Biotech IPO is up to ₹496.25 Cr. The final issue price of CSB Bank IPO is ₹195.00 per share and of Rossari Biotech IPO is ₹425.00 per share.
| CSB Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹193.00 per share | ₹423.00 per share |
| Issue Price (Upper) | ₹195.00 per share | ₹425.00 per share |
| Issue Price (Final) | ₹195.00 per share | ₹425.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 75 shares | 35 shares |
| Fresh Issue Size | 12,30,769 shares | 11,76,470 shares |
| Fresh Issue Size (Amount) | up to ₹24.00 Cr | up to ₹50.00 Cr |
| OFS Issue Size | 1,97,78,298 shares | 1,05,00,000 shares |
| OFS Issue Size (Amount) | up to ₹385.68 Cr | up to ₹446.25 Cr |
| Issue Size Total | 2,10,09,067 shares | 1,16,76,470 shares |
| Issue Size Total (Amount) | up to ₹409.68 Cr | up to ₹496.25 Cr |
CSB Bank IPO opens on Nov 22, 2019, while Rossari Biotech IPO opens on Jul 13, 2020. The closing date of CSB Bank IPO and Rossari Biotech IPO is Nov 26, 2019, and Jul 15, 2020, respectively.
| CSB Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Nov 21, 2019 | Jul 10, 2020 |
| Issue Open | Nov 22, 2019 | Jul 13, 2020 |
| Issue Close | Nov 26, 2019 | Jul 15, 2020 |
| Basis Of Allotment (Tentative) | Dec 02, 2019 | Jul 20, 2020 |
| Initiation of Refunds (Tentative) | Dec 03, 2019 | Jul 21, 2020 |
| Credit of Share (Tentative) | Dec 03, 2019 | Jul 22, 2020 |
| Listing date (Tentative) | Dec 04, 2019 | Jul 23, 2020 |
| Anchor Lockin End date 1 | Jan 01, 2020 | Aug 19, 2020 |
| Anchor Lockin End date 2 | Mar 01, 2020 | Oct 18, 2020 |
CSB Bank IPO P/E ratio is , as compared to Rossari Biotech IPO P/E ratio of 33.81.
| CSB Bank IPO | Rossari Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 50.09 | 95.06 | ||||
| Promoter Shareholding (Post-Issue) | 49.7 | 73 | ||||
| P/E Ratio | 33.81 | |||||
| Market Cap | ₹3382.39 Cr. | ₹2207.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the CSB Bank IPO Retail Individual Investors (RII) are offered 21,00,906 shares while in Rossari Biotech IPO retail investors are offered 21,00,906 shares. Qualified Institutional Buyers (QIB) are offered 63,02,721 shares in CSB Bank IPO and 23,35,294 shares in Rossari Biotech IPO.
| CSB Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 94,54,080 shares | 35,02,940 shares |
| Market Maker Reservation | ||
| QIB | 63,02,721 shares | 23,35,294 shares |
| NII | 31,51,360 shares | 17,51,471 shares |
| RII | 21,00,906 shares | 40,86,765 shares |
| Employee | ||
| Others | ||
| Total | 2,10,09,067 shares | 1,16,76,470 shares |
CSB Bank IPO subscribed 86.91x in total, whereas Rossari Biotech IPO subscribed 79.37x.
| CSB Bank IPO | Rossari Biotech IPO | |
|---|---|---|
| QIB (times) | 62.18x | 85.26x |
| NII (times) | 164.68x | 239.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 44.46x | 7.23x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 86.91x | 79.37x |
